Gilead Sciences (GILD) Net Profit Margin: History & Chart

Gilead Sciences, Inc.(GILD)

Drug Manufacturers - General · Foster City, CA

$146.79-4.20 (-2.78%)

Delayed quote: Sep 8, 2026, 3:20 PM EDT

About Gilead Sciences, Inc.

Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key therapies such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. In response to the 2019 coronavirus pandemic, Gilead provides Veklury, an injectable drug for intravenous administration. Its offerings for liver diseases include Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. Furthermore, Gilead assists patients battling hematological disorders, various cancers, and those undergoing cell therapy, through products like Yescarta, Tecartus, Trodelvy, and Zydelig. Other specialized medicines include Letairis, an oral drug for pulmonary arterial hypertension; Ranexa, also an oral medication, for chronic angina; and AmBisome, a liposomal formulation designed to combat serious invasive fungal infections. Gilead Sciences, Inc. actively engages in collaboration agreements with a diverse range of partners to advance its therapeutic pipeline. These include Arcus Biosciences, Inc., Pionyr Immunotherapeutics Inc., Tizona Therapeutics, Inc., Tango Therapeutics, Inc., Jounce Therapeutics, Inc., Galapagos NV, Janssen Sciences Ireland Unlimited Company, Japan Tobacco, Inc., Gadeta B.V., Bristol-Myers Squibb Company, Dragonfly Therapeutics, Inc., and Merck & Co, Inc. The company was founded in 1987 and its corporate headquarters are situated in Foster City, California.

Foster City, CA

17,000 employees

www.gilead.com

Healthcare / Drug Manufacturers - General

Sector: Healthcare
Industry: Drug Manufacturers - General
CEO: Daniel O'Day

View full financials

GILD Net Profit Margin Metrics

NET PROFIT MARGIN

-10.64%

NET PROFIT MARGIN AVG TTM

-2.19%

NET PROFIT MARGIN AVG 3Y

24.86%

NET PROFIT MARGIN AVG 5Y

22.12%

NET PROFIT MARGIN AVG 10Y

27.11%

NET PROFIT MARGIN AVG 15Y

31.31%

NET PROFIT MARGIN AVG 20Y

32.76%

CURRENT VS TTM AVG

-385.32%

CURRENT VS 3Y AVG

-142.79%

CURRENT VS 5Y AVG

-148.11%

CURRENT VS 10Y AVG

-139.25%

CURRENT VS 15Y AVG

-133.98%

CURRENT VS 20Y AVG

-132.48%

SECTOR MEDIAN · HEALTHCARE

8.98%

median of 90 covered companies

CURRENT VS SECTOR MEDIAN

-218.49%

vs the sector median at left

NAME	MARKET CAP	NET PROFIT MARGIN	TTM	3Y	5Y
Gilead Sciences, Inc. (GILD)	$182.25B	-10.64%	-2.19%	24.86%	22.12%
Abbott Laboratories (ABT)vs ›	$182.82B	11.65%	23.34%	19.20%	17.71%
Novo Nordisk A/S (NVO)vs ›	$200.83B	35.33%	33.96%	33.83%	33.74%
Pfizer Inc. (PFE)vs ›	$158.53B	6.81%	12.51%	14.97%	18.18%
Amgen Inc. (AMGN)vs ›	$213.09B	22.93%	16.61%	20.49%	22.20%
Danaher Corporation (DHR)vs ›	$144.95B	15.95%	15.52%	19.51%	19.37%
Thermo Fisher Scientific Inc. (TMO)vs ›	$224.62B	15.06%	14.95%	14.84%	16.47%
Vertex Pharmaceuticals Incorporated (VRTX)vs ›	$134.35B	34.89%	13.94%	25.44%	29.40%
Bristol-Myers Squibb Company (BMY)vs ›	$132.30B	18.87%	-1.95%	6.91%	3.60%
Intuitive Surgical, Inc. (ISRG)vs ›	$123.94B	28.45%	28.09%	25.67%	26.14%

NAME

MARKET CAP

NET PROFIT MARGIN

TTM

Gilead Sciences, Inc. (GILD)

$182.25B

-10.64%

-2.19%

24.86%

22.12%

Abbott Laboratories (ABT)vs ›

$182.82B

11.65%

23.34%

19.20%

17.71%

Novo Nordisk A/S (NVO)vs ›

$200.83B

35.33%

33.96%

33.83%

33.74%

Pfizer Inc. (PFE)vs ›

$158.53B

6.81%

12.51%

14.97%

18.18%

Amgen Inc. (AMGN)vs ›

$213.09B

22.93%

16.61%

20.49%

22.20%

Danaher Corporation (DHR)vs ›

$144.95B

15.95%

15.52%

19.51%

19.37%

Thermo Fisher Scientific Inc. (TMO)vs ›

$224.62B

15.06%

14.95%

14.84%

16.47%

Vertex Pharmaceuticals Incorporated (VRTX)vs ›

$134.35B

34.89%

13.94%

25.44%

29.40%

Bristol-Myers Squibb Company (BMY)vs ›

$132.30B

18.87%

-1.95%

6.91%

3.60%

Intuitive Surgical, Inc. (ISRG)vs ›

$123.94B

28.45%

28.09%

25.67%

26.14%

Net Profit Margin FAQ

What is the net profit margin for Gilead Sciences, Inc. (GILD)?

The net profit margin for GILD stock is -10.64%.

Is Gilead Sciences, Inc.'s net profit margin high or low?

The net profit margin of -10.64% is 148% below its 5-year average of 22.12%, near the high end of its 5-year range (-134.51%–39.28%).

What is the TTM average net profit margin for Gilead Sciences, Inc. (GILD)?

The TTM average net profit margin for GILD stock is -2.19%.

What is the 3Y average net profit margin for Gilead Sciences, Inc. (GILD)?

The 3Y average net profit margin for GILD stock is 24.86%.

What is the 5Y average net profit margin for Gilead Sciences, Inc. (GILD)?

The 5Y average net profit margin for GILD stock is 22.12%.

What is the 10Y average net profit margin for Gilead Sciences, Inc. (GILD)?

The 10Y average net profit margin for GILD stock is 27.11%.

What is the 15Y average net profit margin for Gilead Sciences, Inc. (GILD)?

The 15Y average net profit margin for GILD stock is 31.31%.

What is the 20Y average net profit margin for Gilead Sciences, Inc. (GILD)?

The 20Y average net profit margin for GILD stock is 32.76%.

DATE	NET PROFIT MARGIN
2026-06-30	-134.51%
2026-03-31	29.04%
2025-12-31	27.55%
2025-09-30	39.28%
2025-06-30	27.68%
2025-03-31	19.72%
2024-12-31	23.56%
2024-09-30	16.61%
2024-06-30	23.21%
2024-03-31	-62.37%
2023-12-31	20.09%
2023-09-30	30.92%
2023-06-30	15.84%
2023-03-31	15.90%
2022-12-31	22.20%
2022-09-30	25.40%
2022-06-30	18.27%
2022-03-31	0.29%
2021-12-31	5.27%
2021-09-30	34.93%
2021-06-30	24.48%
2021-03-31	26.92%
2020-12-31	20.90%
2020-09-30	5.47%
2020-06-30	-64.92%
2020-03-31	27.96%
2019-12-31	45.86%
2019-09-30	-20.79%
2019-06-30	33.07%
2019-03-31	37.40%
2018-12-31	0.05%
2018-09-30	37.47%
2018-06-30	32.17%
2018-03-31	30.23%
2017-12-31	-64.97%
2017-09-30	41.74%
2017-06-30	43.03%
2017-03-31	41.54%
2016-12-31	42.46%
2016-09-30	44.40%
2016-06-30	44.97%
2016-03-31	45.75%
2015-12-31	55.06%
2015-09-30	55.46%
2015-06-30	54.49%
2015-03-31	57.06%
2014-12-31	47.67%
2014-09-30	45.20%
2014-06-30	55.94%
2014-03-31	44.55%
2013-12-31	25.37%
2013-09-30	28.34%
2013-06-30	27.92%
2013-03-31	28.53%
2012-12-31	29.46%
2012-09-30	27.84%
2012-06-30	29.58%
2012-03-31	19.36%
2011-12-31	30.23%
2011-09-30	34.93%
2011-06-30	34.92%
2011-03-31	33.81%
2010-12-31	31.49%
2010-09-30	36.38%
2010-06-30	36.95%
2010-03-31	40.99%
2009-12-31	39.47%
2009-09-30	37.36%
2009-06-30	34.69%
2009-03-31	38.49%
2008-12-31	39.78%
2008-09-30	36.75%
2008-06-30	34.02%
2008-03-31	38.81%
2007-12-31	36.69%
2007-09-30	37.62%
2007-06-30	38.92%
2007-03-31	39.61%
2006-12-31	-185.23%
2006-09-30	-6.97%
2006-06-30	38.69%
2006-03-31	37.91%
2005-12-31	46.22%
2005-09-30	36.32%
2005-06-30	39.57%
2005-03-31	36.50%
2004-12-31	29.83%
2004-09-30	34.72%
2004-06-30	34.86%
2004-03-31	37.02%
2003-12-31	73.08%
2003-09-30	36.48%
2003-06-30	42.02%
2003-03-31	-265.32%
2002-12-31	24.46%
2002-09-30	15.49%

DATE

NET PROFIT MARGIN

2026-06-30

-134.51%

2026-03-31

29.04%

2025-12-31

27.55%

2025-09-30

39.28%

2025-06-30

27.68%

2025-03-31

19.72%

2024-12-31

23.56%

2024-09-30

16.61%

2024-06-30

23.21%

2024-03-31

-62.37%

2023-12-31

20.09%

2023-09-30

30.92%

2023-06-30

15.84%

2023-03-31

15.90%

2022-12-31

22.20%

2022-09-30

25.40%

2022-06-30

18.27%

2022-03-31

0.29%

2021-12-31

5.27%

2021-09-30

34.93%

2021-06-30

24.48%

2021-03-31

26.92%

2020-12-31

20.90%

2020-09-30

5.47%

2020-06-30

-64.92%

2020-03-31

27.96%

2019-12-31

45.86%

2019-09-30

-20.79%

2019-06-30

33.07%

2019-03-31

37.40%

2018-12-31

0.05%

2018-09-30

37.47%

2018-06-30

32.17%

2018-03-31

30.23%

2017-12-31

-64.97%

2017-09-30

41.74%

2017-06-30

43.03%

2017-03-31

41.54%

2016-12-31

42.46%

2016-09-30

44.40%

2016-06-30

44.97%

2016-03-31

45.75%

2015-12-31

55.06%

2015-09-30

55.46%

2015-06-30

54.49%

2015-03-31

57.06%

2014-12-31

47.67%

2014-09-30

45.20%

2014-06-30

55.94%

2014-03-31

44.55%

2013-12-31

25.37%

2013-09-30

28.34%

2013-06-30

27.92%

2013-03-31

28.53%

2012-12-31

29.46%

2012-09-30

27.84%

2012-06-30

29.58%

2012-03-31

19.36%

2011-12-31

30.23%

2011-09-30

34.93%

2011-06-30

34.92%

2011-03-31

33.81%

2010-12-31

31.49%

2010-09-30

36.38%

2010-06-30

36.95%

2010-03-31

40.99%

2009-12-31

39.47%

2009-09-30

37.36%

2009-06-30

34.69%

2009-03-31

38.49%

2008-12-31

39.78%

2008-09-30

36.75%

2008-06-30

34.02%

2008-03-31

38.81%

2007-12-31

36.69%

2007-09-30

37.62%

2007-06-30

38.92%

2007-03-31

39.61%

2006-12-31

-185.23%

2006-09-30

-6.97%

2006-06-30

38.69%

2006-03-31

37.91%

2005-12-31

46.22%

2005-09-30

36.32%

2005-06-30

39.57%

2005-03-31

36.50%

2004-12-31

29.83%

2004-09-30

34.72%

2004-06-30

34.86%

2004-03-31

37.02%

2003-12-31

73.08%

2003-09-30

36.48%

2003-06-30

42.02%

2003-03-31

-265.32%

2002-12-31

24.46%

2002-09-30

15.49%

Net Profit Margin: -10.64%

GILD Profit Margin

GILD Average Net Profit Margin Chart

GILD Current vs Average Net Profit Margin Chart

GILD Net Profit Margin Metrics

GILD Competitors' Net Profit Margin

Margin Comparison

Net Profit Margin Formula & Definition

Net Profit Margin FAQ

GILD Net Profit Margin History

Related Metrics